Can Angels Fill the Venture Capital Void in Life Science?
Tuesday, November 13, 2012 from 5:30 PM to 7:30 PM (PST)
San Francisco, CA
Life Science Angels (LSA) Founder and Chairman Allan May will speak about angels vs. venture capital funding for medical device and life science startups. LSA is the nation's largest angel organization focused solely on early-stage medical device and life-science start-ups, and comprised exclusively of high net worth individuals from the medical device and biotech fields. In 2011, LSA launched the Life Science Angel Network, a consortium of angel groups throughout the US, to increase the syndication and capitalization of highly vetted healthcare startups.
In 2007, Allan joined Dr. Thomas Fogarty, co-founding Emergent Medical Partners, a venture fund focused on early stage medical device company creation and investing. Allan is currently Vice Chair of the Board of the Kauffman Foundation’s Angel Resource Institute (ARI), a nonprofit devoted to promoting and studying angel investing. In 2012, ARI released the Halo Report, the first detailed data tracking early stage investment by angel groups.
Allan has been founder, Chairman, CEO, or investor in over 50 medtech, biotech, and diagnostic startups. He moderated the Entrepreneurship Track at the 2011-2012 FutureMed Programs at Singularity University, and is a member of the editorial board of Elsevier Windhover’s In Vivo magazine. He speaks frequently at universities, conferences and government programs on trends and developments affecting early stage biotech and medtech investing.
This event is cosponsored by Wells Fargo Life Sciences Group and the Entrepreneurship Center of UCSF, Office of Innovation and Technology (ITA).
When & Where
Entrepreneurship Center at UCSF